Hussain M, Atif M, Babar M, Akhtar L. COMPARISON OF EFFICACY AND SAFETY PROFILE OF EMPAGLIFLOZIN VERSUS DAPAGLIFLOZIN AS ADD ON THERAPY IN TYPE 2 DIABETIC PATIENTS. J Ayub Med Coll Abbottabad [Internet]. 2021 Oct. 6 [cited 2025 Apr. 19];33(4):593-7. Available from: https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/9089